News

In patients with MRSA bacteremia, implementing AUC/MIC-guided vancomycin dosing resulted in decreased average troughs and a decrease in daily vancomycin dose administered.

A study found that there was no statistically significant difference in CDI recurrence within 12 weeks between patients receiving oral vancomycin prophylaxis compared those who did not.

In a tiny number of cases, treating HIV with ART actually makes CD4+ T cell levels fall.

Use of Verigene Blood Culture Gram-Negative without stewardship involvement was shown to improve time to optimal therapy, which was primarily driven by decreased time to antibiotic escalation.

In both the lefamulin and moxifloxacin treatment groups, the median time from treatment initiation to clinical response was 4 (3-5) days.

Patients with only a gram-negative infection and/or mixed gram-negative/gram-positive pathogens were more likely to receive IET (22.8%, 270 out of 1184; and 22.8%, 633 out of 2778, respectively) compared with patients with infections caused by only gram-positive organisms (6.5%, 381 out of 5891).

Compared with no pharmacist involvement, a greater number of appropriate antiretroviral regimens were initiated with partial pharmacist involvement (62% vs. 32%, p = 0.0096).

The authors of a new study say the use of antibiotics and proton pump inhibitors are among the list of risk factors for recurring C diff infections.

A survey of nearly 300 pharmacy students found that 91% were aware of PrEP and 61% reported high familiarity with PrEP prescription guidelines, but knowledge gaps still remain.

DONATE-HCV trial offers new hope to those on waiting lists for new hearts and/or lungs.

Plague. West Nile Virus. Zoonotic influenza. What else made the CDC list of the top 8 zoonotic diseases of most concern in the US?

The intersection of technology and infection control comes to life with UV robots.

A large variance in how family physicians prescribe antibiotics couldn’t be explained by patient characterizations, suggesting a need for improving interventions in antimicrobial stewardship programs.

The FDA has issued label updates for a handful of fluoroquinolone antibiotics to note the risk of aortic dissections and aortic aneurysms in certain patients.

More than 80% of ill individuals reported consuming ground beef prior to falling ill, yet health officials have been unable to pinpoint a common supplier, distributor, or brand responsible for this outbreak.

Contagion® will be heading to Orlando, Florida, on Wednesday, May 8, 2019, to report on the annual Making a Difference in Infectious Diseases (MAD-ID) 2019 conference.

Triatoma sanguisugas, an insect also known as a “kissing bug,” can transmit the parasite Trypanosoma cruzi, which causes Chagas disease.

Understanding barriers and facilitators of PrEP could help improve adherence among young men and transgender women of color, a recent study found.

A new review recommends updated guidelines for diagnosing and managing Candida and C diff coinfection.

Here is a look at infectious disease-related US Food and Drug Administration news from the week of April 28, 2019.

We’ve rounded up a list of important US Food and Drug Administration (FDA) and US Department of Agriculture (USDA) recalls from this past week.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

A new analysis of more than half a million knee replacements finds patient-specific factors and certain surgical decisions can make a difference in the rate of infections.

An infamous beauty procedure is causing concern over spa safety failures after 2 clients were diagnosed with HIV.

The final results of the PARTNER study have been published in the journal The Lancet and confirm that an undetectable viral load on HIV treatment renders an individual sexually non-infectious.

Difficulties connecting with physicians mean not all people at risk of acquiring HIV have access to PrEP. Putting nurses on the front lines could change that.

The CDC considers VRE to be a “concerning threat,” and estimates that the bug sickens some 20,000 Americans annually, causing death in roughly 1300 people per year.

Merck, the sole supplier of the MMR vaccine in the United States, is increasing production to meet growing demand from areas where measles outbreaks are ongoing.

As Ebola case counts continue to climb in the ongoing outbreak, emergency preparedness simulations are underway in Uganda.

A third dose of the measles-mumps-rubella vaccine may be a safe and effective response to concerns about waning immunity to mumps among young adults.